With Cancer | Without Cancer | p value | |
Total Number of Patients | 56 | 445 | |
Mean Age ±STD (in years) | 67.4±11.3 | 64.3±15.1 | NS |
Number of women (%) | 87.5% | 87.8% | NS |
Race/Ethnicity | |||
White | 9.5% | 69.6% | NS |
Black | 88.0% | 88.3% | NS |
Native American | - | 0.2% | NS |
Asian Pacific Islander | - | 0.7% | NS |
Other | 2.3% | 3.7% | NS |
Hispanics | 8.1% | 8.3% | NS |
Other Characteristics | |||
Non-smoker | 68.2% | 70.8% | NS |
Ever smoker | 31.8% | 29.2% | NS |
BMI (mean ± STD) | 28.1±5.7 | 29.0±7.7 | NS |
BMI ≥ 30 Kg/m2 | 27.5% | 38.4% | NS |
BMI <20 kgm2 | 3.9% | 8% | NS |
Asthma | 14% | 16.9% | NS |
COPD | 17.6% | 11.1% | NS |
Diabetes mellitus | 39.2% | 27.4% | NS |
Hypertension | 75% | 65.7% | NS |
Hyperlipidemia | 45% | 40.5% | NS |
CAD or MI | 20.4% | 19.5% | NS |
Cerebrovascular accident | 8.1% | 9.9% | NS |
Chronic kidney disease | 18% | 11.3% | NS |
Venous thromboembolism | 16.3% | 12.5% | NS |
Atrial fibrillation | 12% | 8% | NS |
Congestive heart failure | 19.6% | 14.7% | NS |
At least 1 CVD outcome | 39.3% | 33.9% | NS |
At least 1 traditional CVD risk factor | 90.9% | 86.9% | NS |
≥3 traditional CVD risk factors | 36.4% | 32% | NS |
Atrial fibrillation | 12% | 7.9% | NS |
Extra-articular manifestations | 8.9% | 8.1% | NS |
Another autoimmune disease | 20% | 14% | NS |
Rheumatoid Arthritis Characteristics | |||
RA disease duration (years) | 12.2±9.6 | 11.8±8.8 | NS |
RF + | 56.5% | 77.5% | p <0.05 |
ACPA + | 70.6% | 69.8% | NS |
Either RF + or ACPA + | 89.5% | 86.7% | NS |
Pos RF and Pos ACPA | 58.8% | 53.2% | NS |
ANA positive | 47.1% | 39.4% | NS |
CRP >10 * | 71.4% | 62.5% | NS |
ESR rate >42 ** | 81.5% | 61.8% | p <0.05 |
Abnormal hand radiographs | 95.2% | 94.7% | NS |
Joint space narrowing | 61.9% | 69.9% | NS |
Presence of Joint erosions | 66.6% | 66.8% | NS |
SENS (±SD) | 25.4±18.5 | 31.0±21.7 | NS |
Steroids only | 51.1% | 56.6% | NS |
Methotrexate | 31.9% | 41.3% | NS |
Other DMARD | 52.6% | 41.9% | NS |
Only Biologics | 14.3% | 16.5% | NS |
Steroids + any DMARD/Biologics | 30.3% | 36.2% | NS |
Only DMARD/Biologics | 30.3% | 26.3% | NS |